CI

At a glance

ClinicalIndex Comparison Record
Phase 3Completed· 105 enrolled
Drug / intervention
Low dose hCG plus FSH co-trigger +1 moredrug
Likely dose
Low dose hCG plus FSH co-trigger 1,500 IUfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02310919
NCT02310919Phase 3Completed
CompareCT.gov

Concomitant Administration of FSH With a Low Dose of hCG (1,500 IU) Has Equivalent Oocyte Developmental Competence While Decreasing the Exposure to hCG in IVF Cycles: A Double Blind Randomized Control Trial

University of California, San Francisco·interventional·Posted Dec 8, 2014·Updated Apr 29, 2022

In Brief

A Phase 3 clinical trial evaluating Low dose hCG plus FSH co-trigger and Standard dose of hCG for Infertility. Completed, enrolled 105 participants across 1 site.

Detailed Summary

This is a randomized, double-blind, single center clinical trial study to compare oocyte competence and risk of ovarian hyperstimulation syndrome (OHSS) after receiving the standard dose of human chorionic gonadotropin (hCG) ovulation trigger or a lower dose of hCG plus concomitant follicle stimulating hormone (FSH) co-trigger in women undergoing in vitro fertilization (IVF).

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsInfertility
CountriesUnited States
CollaboratorsFerring Pharmaceuticals

Timeline

Phase 3CompletedFinished
201520162017201820192020202120222023202420252026
First PostedDec 8, 2014
Enrollment StartSep 1, 2014
Primary CompletionJun 20, 2018
TodayJul 2, 2026
Enrollment to primary: 3.8 yearsPosted 11.6 years ago

Interventions

Low dose hCG plus FSH co-triggerdrug

Low dose hCG (1,500 IU) plus FSH (450 IU) co-trigger

Standard dose of hCGdrug

Standard dose of hCG (10,000 or 5,000 IU) trigger